CTNNB1 and desmoid tumor: The aims of this study were to prospectively analyze the status of CTNNB1 mutations in consecutive patients with extra-peritoneal desmoid tumors treated with meloxicam, and to determine the significance of mutational status in predicting the efficacy of meloxicam treatment.